Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future.

Autor: Ogunleye OO; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Lagos 100271, Nigeria.; Department of Medicine, Lagos State University Teaching Hospital, Lagos 100271, Nigeria., Godman B; Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.; Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates.; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa., Fadare JO; Department of Pharmacology and Therapeutics, Ekiti State University, Ado Ekiti 362103, Nigeria.; Department of Medicine, Ekiti State University Teaching Hospital, Ado Ekiti 360211, Nigeria., Mudenda S; Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia.; Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka P.O. Box 32379, Zambia., Adeoti AO; Department of Medicine, Ekiti State University Teaching Hospital, Ado Ekiti 360211, Nigeria., Yinka-Ogunleye AF; Nigerian Center for Disease Control, Plot 801, Ebitu Ukiwe Street, Jabi, Abuja 900108, Nigeria., Ogundele SO; Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Lagos 100271, Nigeria.; Department of Medicine, Lagos State University Teaching Hospital, Lagos 100271, Nigeria., Oyawole MR; Department of Pharmacy, Lagos State University Teaching Hospital, Lagos 100271, Nigeria., Schönfeldt M; Child, Youth and School Health Directorate, National Department of Health, Pretoria 0083, South Africa., Rashed WM; Children's Cancer Hospital, Egypt-57357 (CCHE-57357), Cairo 11441, Egypt., Galal AM; Biomedical Research Department, Armed Forces College of Medicine, Cairo 11774, Egypt., Masuka N; CIMAS, Cimas House, Borrowdale Office Park, Borrowdale Road, Harare P.O. Box 1243, Zimbabwe., Zaranyika T; Department of Medicine, University of Zimbabwe College of Health Sciences, Harare P.O. Box MP167, Zimbabwe., Kalungia AC; Department of Pharmacy, School of Health Sciences, University of Zambia, Lusaka P.O. Box 50110, Zambia., Malande OO; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa.; Department of Child Health and Paediatrics, Egerton University, Nakuru P.O.Box 536, Kenya.; East Africa Centre for Vaccines and Immunization (ECAVI), Namela House, Naguru, Kampala P.O. Box 3040, Uganda., Kibuule D; Department of Pharmacology & Therapeutics, Busitema University, Mbale P.O. Box 236, Uganda., Massele A; Department of Clinical Pharmacology and Therapeutics, Hurbert Kairuki Memorial University, 70 Chwaku Road Mikocheni, Dar Es Salaam P.O. Box 65300, Tanzania., Chikowe I; Pharmacy Department, Formerly College of Medicine, Kamuzu University of Health Sciences (KUHeS), Blantyre P.O. Box 278, Malawi., Khuluza F; Pharmacy Department, Formerly College of Medicine, Kamuzu University of Health Sciences (KUHeS), Blantyre P.O. Box 278, Malawi., Taruvinga T; Department of Global Health and Development (GHD), London School of Hygiene and Tropical Medicine (LSHTM), London WC1E 7TH, UK., Alfadl A; National Medicines and Poisons Board, Federal Ministry of Health, Khartoum P.O. Box 303, Sudan.; Department of Pharmacy Practice, Unaizah College of Pharmacy, Qassim University, Unaizah 51911, Saudi Arabia., Malik E; Department of Community Medicine, Faculty of Medicine, University of Khartoum, Khartoum 11111, Sudan., Oluka M; Department of Pharmacology & Pharmacognosy, School of Pharmacy, University of Nairobi, Nairobi P.O. Box 19676-00202, Kenya., Opanga S; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, University of Nairobi, Nairobi P.O. Box 19676-00202, Kenya., Ankrah DNA; Department of Pharmacy, Korle Bu Teaching Hospital, Accra P.O. Box 77, Ghana., Sefah IA; Pharmacy Practice Department, School of Pharmacy, University of Health and Allied Sciences, Hohoe PMB 31, Ghana., Afriyie D; Pharmacy Department, Ghana Police Hospital, Accra P.O. Box CT104, Ghana., Tagoe ET; Department of Management Science, University of Strathclyde, Glasgow G4 0QU, UK., Amu AA; Pharmacy Department, Eswatini Medical Christian University, P.O. Box A624, Swazi Plaza, Mbabane H100, Eswatini., Msibi MP; Faculty of Health Sciences, Department of Medical Laboratory Sciences, Eswatini Medical Christian University, Swazi Plaza P.O. Box A624, Mbabane H100, Eswatini., Etando A; Department of Medical Laboratory Sciences, Faculty of Health Sciences, Eswatini Medical Christian University, Swazi Plaza P.O. Box A624, Mbabane H100, Eswatini., Alabi ME; School of Pharmaceutical Sciences, College of Health Sciences, University of Kwazulu-natal (UKZN), Durban 4001, South Africa., Okwen P; Effective Basic Services (eBASE) Africa, Ndamukong Street, Bamenda 5175, Cameroon.; Faculty of Health and Medical Sciences, Adelaide University, Adelaide 5005, Australia., Niba LL; Effective Basic Services (eBASE) Africa, Ndamukong Street, Bamenda 5175, Cameroon.; Department of Public Health, University of Bamenda, Bambili P.O. Box 39, Cameroon., Mwita JC; Department of Internal Medicine, Faculty of Medicine, University of Botswana, Gaborone P.O. Box 70480, Botswana., Rwegerera GM; Department of Medicine, Sir Ketumile Masire Teaching Hospital, Gaborone P.O. Box 70480, Botswana., Kgatlwane J; Department of Pharmacy, University of Botswana, Gaborone P.O. Box 70480, Botswana., Jairoun AA; Health and Safety Department, Dubai Municipality, Dubai P.O. Box 67, United Arab Emirates.; School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia., Ejekam C; Department of Community Health, Lagos University Teaching Hospital, Idi-Araba, Lagos PMB 21266, Nigeria., Mavenyengwa RT; Medical Microbiology Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare P.O. Box MP167, Zimbabwe., Murimi-Worstell I; School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA., Campbell SM; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa.; Centre for Epidemiology and Public Health, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.; NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK., Meyer JC; Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 02084, South Africa.
Jazyk: angličtina
Zdroj: Vaccines [Vaccines (Basel)] 2022 Sep 17; Vol. 10 (9). Date of Electronic Publication: 2022 Sep 17.
DOI: 10.3390/vaccines10091553
Abstrakt: The introduction of effective vaccines in December 2020 marked a significant step forward in the global response to COVID-19. Given concerns with access, acceptability, and hesitancy across Africa, there is a need to describe the current status of vaccine uptake in the continent. An exploratory study was undertaken to investigate these aspects, current challenges, and lessons learnt across Africa to provide future direction. Senior personnel across 14 African countries completed a self-administered questionnaire, with a descriptive analysis of the data. Vaccine roll-out commenced in March 2021 in most countries. COVID-19 vaccination coverage varied from low in Cameroon and Tanzania and up to 39.85% full coverage in Botswana at the end of 2021; that is, all doses advocated by initial protocols versus the total population, with rates increasing to 58.4% in Botswana by the end of June 2022. The greatest increase in people being fully vaccinated was observed in Uganda (20.4% increase), Botswana (18.5% increase), and Zambia (17.9% increase). Most vaccines were obtained through WHO-COVAX agreements. Initially, vaccination was prioritised for healthcare workers (HCWs), the elderly, adults with co-morbidities, and other at-risk groups, with countries now commencing vaccination among children and administering booster doses. Challenges included irregular supply and considerable hesitancy arising from misinformation fuelled by social media activities. Overall, there was fair to reasonable access to vaccination across countries, enhanced by government initiatives. Vaccine hesitancy must be addressed with context-specific interventions, including proactive programmes among HCWs, medical journalists, and the public.
Databáze: MEDLINE